Purpose Adolescents and young adults (AYAs) with cancer are known to have complex medical and psychosocial needs throughout treatment; however, information is lacking about the challenges AYA survivors face after treatment has ended. Focus groups were conducted using a concept mapping framework to better understand the most important issues these patients face in transitioning to survivorship and how prepared they felt to face them. Methods AYAs diagnosed between 18 and 39 years old and at least 2 years post-treatment participated in one of six focus groups based on age group and follow-up status. Using a concept mapping design, participants provided important issues during the transition to survivorship and appraised them on three core areas of interest. Results Analyses revealed salient themes shared across age and follow-up group status, particularly related to the psychosocial, emotional, and cognitive effects of treatment. Differential concerns included those related to patients' developmental concernsnamely, finding a new identity, financial burden of treatment, and fertility concerns after treatment. Conclusions AYA cancer survivors continue to have a myriad of issues beyond the immediate treatment phase. Despite a complex list of challenges, these issues largely remained unaddressed by their oncology provider and left patients feeling overwhelmingly ill-prepared to manage their transition to survivorship. Implications for Cancer Survivors AYA cancer survivors have many unaddressed concerns as they transition out of active cancer treatment, largely related to developmental issues they are facing. Survivorship care for these patients would benefit from care planning that takes these unique concerns into account.
Background
The diagnosis and treatment of cancer is a life-changing time for most people and can result in a wide array of physical, emotional, and practical changes for patients. There are currently over 12 million survivors of cancer, and the complexities of cancer survivorship are becoming increasingly better understood in adult populations. Within this adult population, however, are approximately 500,000 adolescents and young adults (AYAs), aged 15 to 39, who are survivors of childhood or adult-onset cancers [1, 2] . These patients often have unique life circumstances that make their survivorship concerns quite different from their older counterparts. They may be just reaching developmental milestones of graduating school, attending college, starting their career, dating and marriage, or having children.
AYAs are often at high risk for medical and psychosocial sequelae from cancer and its treatment [3] [4] [5] [6] [7] . Indeed, AYAs who survive cancer for more than 5 years have a higher relative risk of a secondary malignant neoplasm (SMN) compared with the general population and have a higher absolute risk of SMN compared with younger or older cancer survivors [8] . Unlike older patients, they may have concerns about fertility [9, 10] and how/if they will be able to have children of their own after treatment. They are often more dependent on parents compared to their peers [11] , and have difficulties in intimate relationships or obtaining full-time employment [10, 12] . Young cancer patients have lower levels of well-being compared to other age groups [13, 14] , and have been reported to experience anxiety due to many uncertainties when transitioning from active treatment into the survivorship phase [15] .
Survivorship encompasses a myriad of issues that range from late and long-term effects from cancer treatment, risk of secondary malignancies, on-going psychosocial distress, to risk of recurrence. In 2005, a seminal report from the Institute of Medicine (IOM), BFrom Cancer Patient to Cancer Survivor: Lost in Transition^, highlighted the need to recognize survivorship as a distinct phase in cancer care and to address the concerns of survivors [16] . The IOM strongly recommended that all patients receive at the completion of therapy a customized treatment summary and a survivorship care plan (SCP) that details a plan of ongoing care, including follow-up schedules for visits and testing, as well as recommendations for early detection and management of treatment-related effects (i.e., pain, fatigue, premature menopause, depression/anxiety) and other health problems. And yet, the majority of young adult survivors receive inadequate survivorship care with minimal surveillance for late effects [7, 17] .
Adherence to surveillance and follow-up care has been largely unexplored in this population. It is known that rates of treatment non-adherence are high, ranging from 27 to 60% [18, 19] , and are likely higher than in any other cancer population [20, 21] . These issues point to the need to better understand the salient concerns of this vulnerable population as they transition to survivorship, with the goal of improving survivorship care for AYAs by understanding and working to dismantle potential barriers to follow-up adherence.
This pilot study aimed to explore these survivorship concerns through a concept mapping analysis. Concept mapping relies on the premise that patients are the true Bexperts^on their own experience, and uses an inductive approach to capture and analyze this experience through quantitative methods. We aimed to better understand the most salient concerns of AYAs as they transitioned from active treatment to survivorship, how well they felt that these concerns were addressed in their care, and how prepared they felt in dealing with these concerns. Participants were young adult cancer survivors of adult-onset malignancies at a single National Cancer Institute (NCI)/National Comprehensive Cancer Network (NCCN)-designated cancer center using a focus group approach.
Methods
This study utilized 6 focus groups to explore the salient concerns of AYAs during their transition to survivorship. To examine potential age-group differences survivors were stratified by age at diagnosis: 18-24, 25-30, or 31-39 years old. In addition, we examined group differences based on whether patients continued their recommended follow-up at our center or if they had been lost to follow-up (i.e., did not adhere to suggested follow-up schedule within one calendar year from the date of the study's recruitment).
Eligibility criteria included survivors who (1) were diagnosed between 18 and 39 years of age, (2) were diagnosed between January 1, 2005, and December 31, 2011, (3) received all of their treatment at our center, (4) completed their planned cancer treatment, and (5) are currently living. Our institutional Tumor Registry identified 1327 patients (827 female, 500 male) who fit the age and timeframe of diagnosis criteria for this study. Using the electronic medical record, a research associate verified how many of these potential participants met criteria 3-5 noted Focus groups Participants were stratified by age at diagnosis and follow-up status (survivors who continued to follow-up and those who no longer followed-up). These two groups were then divided by participants' age at diagnosis: 18-24, 25-30, or 31-39. Groups were designated with labels A, B, and C to designate follow-up groups, and AA, BB, and CC to designate nonfollow-up groups. Using a concept mapping framework, patients were asked to brainstorm responses to the following prompt statement. "The transition from active cancer treatment to survivorship is an important one. List the issues that made this transition difficult or problematic for you. Examples may be the loss of support from your medical team (your 'safety net') or going back to work." Participants generated as many statements as they could and brainstorming was complete when they felt that all issues had been covered. During a short break, all statements were written individually on 3 × 5 index cards. The next phase of data generation involved participants grouping all statements into Bpiles that make sense to you.T hey were asked to generate as many groups as they felt were necessary, to not put all cards into one group, or each card into a separate group. After all groupings were completed, participants were asked to label each group with a title or statement that captured the essence of that group. These instructions were repeated verbatim so as not to influence patients' generation of themes, with the prompt that most groups sorted cards into five to ten piles if multiple requests for assistance were made.
The final phase of the focus group asked participants to rate each statement on a 1 (not at all) to 5 (very much) Likert scale on: Importance (how important was this issue to you during your transition to survivorship); Addressed (how well was this issue addressed in your medical care); and Prepared (how prepared did you feel in handling this issue as you transitioned to survivorship). The total time to complete all phases of brainstorming, sorting, and rating took approximately 90 min. Participants received a light breakfast during the focus group and a $50 honorarium for completion of the study.
Data analysis Data were analyzed using the Concept System Global Max program [22] . This analysis uses non-metric multidimensional scaling (MDS) to sort statements onto a twodimensional point map, with those statements that are grouped together by participants being closer together and statements that are grouped together less frequently being further apart on the map. Next a cluster analysis was performed using the X-Y coordinates for each point to group statements into Bclustersr epresenting the underlying theme or structure of the grouping. Cluster maps were created for each group which provided a visual representation of a grouping of similar ideas. Cluster rating maps were then created for each group to represent the variables of Importance, Addressed, and Prepared. These maps show the averaged ratings of the themes within each cluster.
All focus groups were analyzed separately in an attempt to see whether group differences would appear according to age group or follow-up status. This resulted in 6 separate cluster analyses. Cluster solutions were examined for each focus group by examining solutions in reverse order and determining which cluster solution resulted in the least clusters while maintaining interpretability of the data. The most meaningful solution for each group was determined by consensus of the study authors The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Results
Of 1327 potential participants that met study criteria 1 (diagnosed between 18 and 39 years old), 229 met further study criteria and were eligible to participate, and 27 survivors agreed Fig. 3 Sample comparisons of Importance versus Addressed appraisals and Importance versus Prepared appraisals to participate in this study. Participant demographics are illustrated in Table 1 . Six focus groups were conducted with group sizes ranging from 1 to 8 participants. The brainstorming portion of each focus group resulted in an average of 46 statements (range 37-67) generated in each group. Analyses were conducted separately for each group in an effort to compare and contrast salient themes across age groups and follow-up status. Data for group CC are not included in analyses as only one survivor participated in this group.
Multidimensional scaling and hierarchical cluster analysis Cluster solutions were examined for each focus group, with the most meaningful solutions ranging from 5 to 8 clusters. A sample cluster map is shown in Fig. 1 . For each group, we aimed to find the cluster solution with the lowest bridging and stress values while also maintaining the integrity of the data. The domains of Importance, Addressed, and Prepared are represented in Fig. 2 , with more layers on a cluster indicating a higher rating of that domain (i.e., more important, better addressed, or more prepared for). All sample figures represent data for group B which was our largest focus group. The areas rated as most important for each group include: group A-factors impeding life goals (i.e., Delay in job/career); group AApositive life changes after treatment (i.e., Trying to see the good in life); group B-developing a new identity (Being a 'survivor'); group BB-financial toxicity of treatment (i.e., Insurance issues); group C-fears after cancer treatment (i.e., Fear of life not returning to normal). Areas participants rated as being least addressed in their transition to survivorship were: group Anavigating relationships (i.e., Others don't know what to say); group AA-psychosocial difficulties (i.e., Others not understanding lingering effects); group B-cognitive effects of treatment (i.e., Word-finding issues); group BB-negative psychosocial effects of treatment (i.e., Loss of relationships); group C-physical effects of treatment (i.e., Fatigue). Finally, areas that participants rated as feeling least prepared for were: group A-post-treatment support (i.e., Conflicting information about follow-up); group AA-ongoing emotional effects of treatment (i.e., Anxiety); group B-cognitive effects of treatment (i.e., Memory loss); group BB-negative psychosocial effects of treatment (i.e., Loss of relationships); group Cphysical effects of treatment (i.e., Fatigue).
For each of the five groups, analyses were conducted to compare how each concept map theme was rated on Importance versus Addressed, as well as comparisons of Importance versus Prepared (Appendix Tables 2 and 3 ). For every theme in each of the five groups, survivors rated each lower in Addressed versus Importance and lower in Prepared versus Importance with one exception-group AA felt that BAdjusting to a new normal^was well-addressed in their care and they felt well-prepared to cope with this issue. Figure 3 shows comparisons of Importance versus Addressed appraisals, as well as Importance versus Prepared appraisals.
Group similarities and differences In an effort to examine how the salient concerns of each group may have compared and contrasted to one another, cluster map solutions were compared across all groups. Four key themes emerged that were similar across many groups: ongoing effects of treatment (physical/emotional/cognitive), navigating follow-up care, psychosocial concerns, and adjusting to a new normal.
While many of our participants, regardless of age or followup status, expressed similar concerns in their adjustment to survivorship, a few novel concerns did emerge for certain groups, largely in line with developmental considerations for these patients. Concerns related to the financial burden of treatment were expressed by our 25-30-year-old groups regardless of follow-up status, while issues related to fertility and family planning were expressed by groups BB and C. Issues related to maintaining independence and moving out of the patient role were expressed by group BB, while factors impeding life goals and developing a new identity were expressed by groups A and B (18-24-and 25-30-year-old follow-up). Finally, group AA (18-24-year-old follow-up) was the only group to describe positive life changes after treatment.
Conclusions
AYAs have complex medical and psychosocial needs throughout their cancer treatment that continue well after treatment ends [7, [23] [24] [25] . There are, however, no guidelines specific for this population regarding management of long-term treatment effects, monitoring for secondary malignancies, or preventative health measures. In contrast, pediatric cancer survivors have thorough survivorship guidelines available through the Children's Oncology Group [26] and NCCN provides treatment and survivorship guidelines for adults [27] ; however, neither specifically addresses concerns of AYAs.
Our study expands on prior work [24, 28] illustrating that AYAs continue to have many issues long after cancer treatment has ended that are related to the ongoing physical and psychosocial effects of treatment. Regardless of continued follow-up care after completing treatment, young adult cancer survivors face a myriad of issues which remain largely unaddressed by their oncologist or other healthcare provider. Though these issues vary in priority among age groups, late effects from treatment, on-going psychosocial issues, and navigating follow-up care were unifying themes for our participants. These emerging themes did not appear to relate to age group or whether continued oncology care was pursued.
This study contributes to previous research with the findings that differentiate a group of patients often lumped together under the AYA umbrella of 18-39 year olds, namely those aged 25-30. The AYA age range encompasses a number of developmental milestones that many of their peers are moving through, yet AYAs are often delayed in achieving, if able to approach at all [29] . While many of the younger patients had concerns related to their dependence on parents, achieving life goals, and finding a new identity after cancer, our older patients described concerns related to the financial impact of treatment and issues related to family planning. Our middle group, however, appeared to struggle the most with leaving the patient role and finding their bearings again, something that the youngest group may have had less difficulty with as they likely continued to be at least somewhat reliant on parents, whereas the oldest group had firmly established their sense of adulthood before diagnosis. This group also struggled the most with the financial impact of their care, perhaps because younger patients remained on their parents' insurance or received financial help and the oldest cohort had established insurance coverage through their own professions. In fact, the particular statements generated by this middle group include concerns about paying out-of-pocket for medical expenses, insurance issues, and trying to figure out job benefits. This age group had the largest mean discrepancies between issues rated as Important versus Addressed or Prepared, indicating that while their mean ratings for important issues were in line with other groups, they felt these concerns were the least addressed and they were the least prepared to deal with them compared to other age groups.
Another interesting finding relates to the positive life changes expressed by group AA. They were the only group to share positive effects from treatment and shared quite a few: BTrying to see the good in life,^BChanged perspective on life's problems,^BFeelings of gratitude,^and BSearching for meaning/purpose in life.^This group also ranked their concerns as being better addressed and being better able to manage them than other groups on average. This may help explain why this group did not seek follow-up care after treatment ended: a positive outlook may negate the concerns of recurrence and contribute to survivors not appreciating the importance of longterm follow-up.
Through concept mapping, we were able to analyze a unique facet of the participants' concerns-not only which issues were important in their transition to survivorship, but which went unaddressed in their medical care and what were they least prepared to cope with, along with the interplay of all of these factors. Of particular concern is that while many of these concerns were rated as quite important to these survivors, they were also rated as issues that were ill-addressed in their cancer care and that they felt unprepared in coping with in survivorship. Each of the five groups expressed psychosocial concerns/ navigating relationships as being an important issue for them, yet it was consistently rated as one of the least addressed areas in their care. Physical and cognitive effects of treatment were also rated as the least addressed areas and ones that patients felt ill-prepared in coping with.
The lack of communication about these issues with healthcare providers suggest that as survivorship care plans (SCPs) evolve from theoretical documents to standards of care across cancer centers, they may be particularly beneficial for AYAs. A recent systematic review on psychosocial outcomes of AYAs found that their experiences are nuanced and meeting their informational needs and providing treatment-related education may improve their follow-up care [30] . As AYAs continue to have a significant fear of recurrence [31] , tailored SCPs may have a role in providing the communication and knowledge to allay some of these fears. SCPs may provide a wealth of information regarding one's own risks related to treatment, as well as health information addressing the many issues shared among AYAs. What is of particular importance is the need to tailor these SCPs to cover the most salient concerns for where a particular patient may be on their developmental trajectory. It is clear from these data that much more needs to be done to address the psychosocial, cognitive, and emotional effects of cancer treatment, as well as providing education and resources for those experiencing financial toxicity of cancer care.
Study limitations
The paucity of participants in some of the focus groups is a limitation, especially for group CC. As noted in AYA oncology literature, enrolling AYAs onto clinical studies remains challenging [32] . Despite four survivors committing to participate in focus group CC, only one survivor participated which does not allow for interpretation of this group. Additionally, statistical interpretation of group differences is not possible due to small sample sizes.
Clinical implications AYA cancer survivors have long-lasting issues beyond the immediate post-therapy phase. AYAs desire more health information about their long-term risks associated with their cancer and treatment history, and they are dealing with ongoing psychosocial issues that may impede their personal growth and development as young adults. Communication with healthcare providers is key, and survivorship care plans specific for AYAs that are tailored to their developmental needs should be considered. 
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